Who is sponsoring NCT03590132?

NCT03590132 is sponsored by University of Georgia.

What drugs are being tested in NCT03590132?

Interventions in NCT03590132: Strong African American Families Program, Strong African American Families--Teen Program.

What condition does NCT03590132 study?

NCT03590132 studies Adolescent Alcohol Use.

Is NCT03590132 still recruiting?

NCT03590132 is currently completed. Last updated 19 June 2019.

Last reviewed 2019-06-19 · How we verify

NCT03590132: SAAF-STEPS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Strong African American Families STEPS Project

Completed Phase 4 Last updated 19 June 2019

What this trial tests

Phase 4 trial testing Strong African American Families Program in Adolescent Alcohol Use in 472 participants. Completed in 30 November 2018.

Timeline

10 December 2012

Primary endpoint
30 November 2018

30 November 2018

Quick facts

Lead sponsor	University of Georgia
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	prevention
Enrollment	472
Start date	10 December 2012
Primary completion	30 November 2018
Estimated completion	30 November 2018

Drugs / interventions tested

Strong African American Families Program
Strong African American Families--Teen Program

Conditions studied

Adolescent Alcohol Use — all drugs for Adolescent Alcohol Use →

Sponsor

University of Georgia

Who can join

Adults 11 to 13, any sex, with Adolescent Alcohol Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The most common approach to preventing alcohol use involves providing a well-designed program in preadolescence just prior to or upon entering middle school. This approach does not have long-lasting effects or address the risk factors that lead many youth to use alcohol in high school. This study tested a strategy that compares offering effective programs at the transition to middle school and the transition to high school with only offering a program at either one of the transitions or no programs at all.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Family-based prevention programmes for alcohol use in young people.
Gilligan C, Wolfenden L, Foxcroft DR, Williams AJ, et al · · 2019 · cited 15× · PMID 30888061 · DOI 10.1002/14651858.cd012287.pub2
Family-Centered Prevention to Reduce Discrimination-Related Depressive Symptoms Among Black Adolescents: Secondary Analysis of a Randomized Clinical Trial.
Kogan SM, Kwon E, Brody GH, Azarmehr R, et al · · 2023 · cited 6× · PMID 37910105 · DOI 10.1001/jamanetworkopen.2023.40567
Family-Centered Prevention Attenuates the Association Between Structural Racism Risk and Black Adolescents' Low Self-regulation and Externalizing Behaviors: Secondary Analysis of a Randomized Clinical Trial.
Kogan SM, Reck AJ, Tiwari B, Thapha JR, et al · · 2025 · PMID 40676489 · DOI 10.1007/s11121-025-01828-5

Verify or expand the search:

Other recruiting trials for Adolescent Alcohol Use

Currently open trials in the same condition.

NCT07059078 — Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care · NA · recruiting
NCT06486688 — Centralized Virtual SBIRT for Pediatric Primary Care · NA · recruiting

Other University of Georgia trials

Trials by the same sponsor.

NCT07173816 — Optimizing PrEP Uptake for African American Women in the South by Empowering Women to Make Informed HIV Prevention and S · NA · not yet recruiting
NCT06799702 — Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inje · NA · not yet recruiting
NCT06987526 — Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alco · NA · recruiting
NCT06193343 — Steps Towards Osteoarthritis Prevention · NA · recruiting
NCT06424756 — Effects of an Antioxidant Supplement on Blood Vessel Health · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03590132 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Georgia
Last refreshed: 19 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03590132.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing